Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

752 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dual combined antiviral treatment with remdesivir and nirmatrelvir/ritonavir in patients with impaired humoral immunity and persistent SARS-CoV-2 infection.
Pasquini Z, Toschi A, Casadei B, Pellegrini C, D'Abramo A, Vita S, Beccacece A, Bussini L, Chionsini MC, Dentale N, Cantiani A, Lazzarotto T, Bartoletti M, Nicastri E, Zinzani P, Giannella M, Viale P. Pasquini Z, et al. Among authors: viale p. Hematol Oncol. 2023 Dec;41(5):904-911. doi: 10.1002/hon.3206. Epub 2023 Jul 15. Hematol Oncol. 2023. PMID: 37452579
Environmental Contamination by SARS-CoV-2 During Noninvasive Ventilation in COVID-19.
Dell'Olio A, Vocale C, Primavera A, Pisani L, Altavilla S, Roncarati G, Tumietto F, Viale P, Re MC, Lazzarotto T, Nava S, Ranieri VM, Tonetti T. Dell'Olio A, et al. Among authors: viale p. Respir Care. 2023 Jan;68(1):1-7. doi: 10.4187/respcare.10323. Epub 2022 Nov 15. Respir Care. 2023. PMID: 36379641 Free PMC article.
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia.
Gatti M, Pascale R, Cojutti PG, Rinaldi M, Ambretti S, Conti M, Tedeschi S, Giannella M, Viale P, Pea F. Gatti M, et al. Among authors: viale p. Int J Antimicrob Agents. 2023 Jan;61(1):106699. doi: 10.1016/j.ijantimicag.2022.106699. Epub 2022 Dec 2. Int J Antimicrob Agents. 2023. PMID: 36464151
Risk factors for Gram-negative bacterial infection of cardiovascular implantable electronic devices: multicentre observational study (CarDINe Study).
Pascale R, Toschi A, Aslan AT, Massaro G, Maccaro A, Fabbricatore D, Dell'Aquila A, Ripa M, Işık ME, Kızmaz YU, Iacopino S, Camici M, Perna F, Akinosoglou K, Karruli A, Papadimitriou-Olivgeris M, Kayaaslan B, Bilir YA, Evren Özcan E, Turan OE, Işık MC, Pérez-Rodríguez MT, Yagüe BL, Quirós AM, Yılmaz M, Petersdorf S, De Potter T, Durante-Mangoni E, Akova M, Curnis A, Gibertoni D, Diemberger I, Scudeller L, Viale P, Giannella M; CarDINe Study Group. Pascale R, et al. Among authors: viale p. Int J Antimicrob Agents. 2023 Mar;61(3):106734. doi: 10.1016/j.ijantimicag.2023.106734. Epub 2023 Jan 21. Int J Antimicrob Agents. 2023. PMID: 36690123 Free article.
Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders.
Mikulska M, Testi D, Russo C, Balletto E, Sepulcri C, Bussini L, Dentone C, Magne F, Policarpo S, Campoli C, Miselli F, Cilli A, Ghiggi C, Aquino S, Di Grazia C, Giannella M, Giacobbe DR, Vena A, Raiola AM, Bonifazi F, Zinzani P, Cavo M, Lemoli R, Angelucci E, Viale P, Bassetti M, Bartoletti M. Mikulska M, et al. Among authors: viale p. Br J Haematol. 2023 May;201(4):628-639. doi: 10.1111/bjh.18690. Epub 2023 Feb 20. Br J Haematol. 2023. PMID: 36806152
A descriptive case series of the relationship between maintenance of conservative PK/PD efficacy thresholds of dalbavancin over time and clinical outcome in long-term treatment of staphylococcal osteoarticular infections.
Gatti M, Viale P, Cojutti PG, Zamparini E, De Paolis M, Giannella M, Pea F, Tedeschi S. Gatti M, et al. Among authors: viale p. Int J Antimicrob Agents. 2023 May;61(5):106773. doi: 10.1016/j.ijantimicag.2023.106773. Epub 2023 Mar 4. Int J Antimicrob Agents. 2023. PMID: 36878410
Effect of a Fourth Dose of mRNA Vaccine and of Immunosuppression in Preventing SARS-CoV-2 Breakthrough Infections in Heart Transplant Patients.
Masetti M, Scuppa MF, Aloisio A, Giovannini L, Borgese L, Manno S, Tazza B, Pascale R, Bonazzetti C, Caroccia N, Sabatino M, Spitaleri G, Viale P, Giannella M, Potena L. Masetti M, et al. Among authors: viale p. Microorganisms. 2023 Mar 15;11(3):755. doi: 10.3390/microorganisms11030755. Microorganisms. 2023. PMID: 36985328 Free PMC article.
752 results